While there is a shortage of testing kits, manpower and capacities, India does not have other scalable testing options, report Vinay Umarji and Sohini Das. IMAGE: A medical worker collects the......
Several US-based firms, sources say, are lobbying with regulatory authorities over the price-control framework, which is hurting their margins. Weeks before US President Barack Obama’s visit......
FIPB on Monday cleared Rs 6,400-crore (Rs 64-billion) foreign direct investment proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. "The proposal of......
A Planning Commission expert groupon Tuesdayrecommended that all mergers and acquisitions (M&As) in the pharmaceutical industry should be cleared by competition watchdog, CCI to ensure that such......
India has rejected a drug patent application of a United States multinational pharma company, paving the way for easy access to an important life-saving medication for HIV patients across the......
Wockhardt's efforts to restructure its operations have received a boost with the Bombay high court declining to grant an injunction sought by a section of its investors to stall the divestment of......